Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nancy S. Melberg is active.

Publication


Featured researches published by Nancy S. Melberg.


Ophthalmology | 1994

Visual Results after Surgical Removal of Subfoveal Choroidal Neovascular Membranes

Matthew A. Thomas; John D. Dickinson; Nancy S. Melberg; Hector E. Ibanez; Ranjit S. Dhaliwal

PURPOSE The authors report their experience with the surgical removal of subfoveal choroidal neovascularization. Correlations between preoperative characteristics and final postoperative visual acuity are explored. METHODS A retrospective study of 159 consecutive patients was performed between February 1990 and August 1993. Follow-up of 2 or more months was available for 147 eyes: presumed ocular histoplasmosis syndrome, 67 eyes; age-related macular degeneration, 41 eyes; myopia, 10 eyes; multifocal choroiditis, 9 eyes; idiopathic, 8 eyes; angioid streaks, 4 eyes; and miscellaneous, 8 eyes. RESULTS Sixty-seven eyes had presumed ocular histoplasmosis syndrome: mean follow-up was 10.5 months. Visual acuity was stable or improved in 56 (83%) eyes and 20/40 or greater in 21 (31%) eyes. Mean interval to best visual acuity was 3 months. A recurrence rate of 37% had no significant effect on final visual outcome (P = 0.952). Forty-one eyes had age-related macular degeneration: mean follow-up was 15 months. Visual acuity was improved in only five (12%) eyes and was 20/40 or greater in only two (5%) eyes. The interval to best visual acuity was 5 months. A recurrence rate of 27% had not significant effect on final visual outcome (P = 0.31). The visual results and recurrence rates for eyes with less common disorders are presented. CONCLUSION The surgical excision of subfoveal choroidal neovascularization may stabilize or improve visual acuity in selected cases. Patients with focal disorders of the retinal pigment epithelium-Bruchs membrane complex appear to have a better surgical outcome than those with diffuse disease.


Ophthalmology | 1995

Nuclear Sclerotic Cataract after Vitrectomy in Patients Younger than 50 Years of Age

Nancy S. Melberg; Matthew A. Thomas

PURPOSE To evaluate the occurrence of cataract formation after pars plana vitrectomy and gas-fluid exchange in patients younger than 50 years of age. METHODS Twenty-eight patients younger than 50 years of age with bilaterally symmetric crystalline lenses underwent pars plana vitrectomy and gas-fluid exchange in one eye. Postoperatively, lens photographs were used to assess any asymmetry between the surgical and nonsurgical eye. Lens photographs were graded by three independent masked observers using the Lens Opacities Classification System III (LOCS III). Significant cataract progression was defined as either cataract extraction in the surgical eye or a greater than a 0.9 LOCS III unit difference in lens opacity between the surgical and nonsurgical eye. Results were compared with 28 patients older than 50 years of age who had undergone identical surgery. RESULTS In only 7% of patients younger than 50 years of age (mean age, 36.5 years; range, 16-47 years) did significant lens opacity develop in the surgical eye compared with the nonsurgical eye during the follow-up period (mean follow-up, 25.4 months; range, 12-43 months). Of patients older than 50 years of age (mean age, 68.2 years; range, 51-85 years), 79% developed significant lens opacity in the surgical eye compared with the nonsurgical eye during the follow-up period (mean follow-up 27.3 months; range, 12-49 months). The difference in cataract progression between patients younger than 50 years of age and patients older than 50 years of age was statistically significant (P < 0.0000001). CONCLUSION Pars plana vitrectomy with gas-fluid exchange is minimally cataractogenic within the first few years in patients younger than 50 years of age.


American Journal of Ophthalmology | 1995

Visual Field Loss After Pars Plana Vitrectomy With Air/Fluid Exchange

Nancy S. Melberg; Matthew A. Thomas

PURPOSE To report the postoperative finding of a dense, permanent, peripheral temporal visual field defect in the treated eyes of three patients who underwent pars plana vitrectomy with air/fluid exchange. METHODS The patients charts were reviewed. RESULTS Visual field loss after pars plana vitrectomy and air/fluid exchange occurs and may be caused by mechanical trauma to the optic nerve head. CONCLUSION Great caution is advised when aspirating directly over the optic nerve with any extrusion instrument.


Retina-the Journal of Retinal and Vitreous Diseases | 1996

The surgical removal of subfoveal choroidal neovascularization. Ingrowth site as a predictor of visual outcome

Nancy S. Melberg; Matthew A. Thomas; Dean B. Burgess

Purpose: The authors determine the significance of location of the ingrowth site of subfoveal choroidal neovascularization (CNV) as a preoperative indicator of postsurgical visual acuity. Design: A retrospective review is given of preoperative fluorescein angiograms and color fundus photographs for 84 eyes with subfoveal CNV due to the following etiologies: presumed ocular histoplasmosis syndrome (POHS) = 67 eyes; multifocal choroiditis= 9 eyes; idiopathic = 8 eyes. The ingrowth site of the subfoveal CNV was classified as identifiable or not identifiable. If identifiable, the ingrowth site was further classified as extrafoveal, juxtafoveal, or subfoveal. Correlations between CNV ingrowth site location and postoperative visual acuity were made. Results: The ingrowth site for subfoveal CNV was identifiable preoperatively in 60 eyes (71%). Of 31 eyes with an extrafoveal ingrowth site, 18 (60%) had a final visual acuity of 20/40 or better. Of 12 eyes with a juxtafoveal ingrowth site and 18 eyes with a subfoveal ingrowth site, only 2 (7%) had a final visual acuity of 20/40 or better. If the ingrowth site was not identifiable or identifiable and subfoveal in location (N=42), 76% of eyes had a final visual acuity of 20/200 or worse. Conclusion: The ingrowth site of subfoveal CNV can be identified in the majority of eyes with POHS, multifocal choroiditis, or idiopathic membranes. A significant number of subfoveal CNV will have an extrafoveal ingrowth site. Eyes with an extrafoveal ingrowth site have a favorable visual prognosis after the surgical removal of the CNV. If the ingrowth site is subfoveal or not identifiable, the visual prognosis after surgery is guarded.


Ophthalmology | 1995

Cotton-wool spots and the early diagnosis of giant cell arteritis.

Nancy S. Melberg; M. Gilbert Grand; J. Paul Dieckert; Neal P. Barney; Mark S. Blumenkranz; Diane E. Boone; James C. Folk; Theodore J. Stransky

BACKGROUND Giant cell arteritis is a common cause of severe visual loss in older individuals. Patients often present to the ophthalmologist having already lost vision in one eye. Detection of early ophthalmoscopic signs that precede irreversible visual loss in giant cell arteritis would allow preventative treatment in an otherwise frequently blinding disease. METHODS Case presentations. RESULTS Seven patients with mild visual symptoms and results of an ophthalmologic examination significant for cotton-wool spots were found to have giant cell arteritis. On specific questioning, six of seven patients described constitutional symptoms consistent with giant cell arteritis. Six patients had an abnormally elevated Westergren erythrocyte sedimentation rate. Temporal artery biopsy confirmed giant cell arteritis in six patients. The seventh patient received a diagnosis of polymyalgia rheumatica. Prompt treatment with corticosteroids led to preservation of vision and uneventful resolution of the cotton-wool spots in all seven patients. CONCLUSION Cotton-wool spots are an early ophthalmoscopic finding in giant cell arteritis and can precede severe visual loss. Recognition of the significance of cotton-wool spots, use of laboratory studies, and prompt treatment may preserve vision in an otherwise frequently blinding disease.


Ophthalmology | 1996

Managing Recurrent Neovascularization after Subfoveal Surgery in Presumed Ocular Histoplasmosis Syndrome

Nancy S. Melberg; Matthew A. Thomas; John D. Dickinson; Shailaja Valluri


Ophthalmology | 1993

Corticosteroid-induced Ocular Hypertension in the Treatment of Aphakic or Pseudophakic Cystoid Macular Edema

Nancy S. Melberg; R. Joseph Olk


Ophthalmology | 1996

Success with Macular Hole Surgery

Nancy S. Melberg; Travis A. Meredith


Ophthalmic Surgery and Lasers | 1996

Management of Idiopathic Macular Holes

Sandeep Saxena; Nancy S. Melberg; Matthew A. Thomas


Archives of Ophthalmology | 1996

Successful feeder vessel laser treatment of recurrent neovascularization following subfoveal surgery

Nancy S. Melberg; Matthew A. Thomas

Collaboration


Dive into the Nancy S. Melberg's collaboration.

Top Co-Authors

Avatar

Matthew A. Thomas

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Diane E. Boone

University of Iowa Hospitals and Clinics

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Neal P. Barney

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar

David F. Williams

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar

Dean B. Burgess

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

M. Gilbert Grand

Washington University in St. Louis

View shared research outputs
Researchain Logo
Decentralizing Knowledge